Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Navan, Inc. | 8,346,792 | reported | 07 Jan 2026 | tx 17+24,224,127−72,410,837 |
| CM Life Sciences III Inc. | 0 | reported | 09 Nov 2023 | tx 8−59,695,246 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Jan 2026 | PURCHASE | Navan, Inc. | 46,337 | 18.11 USD | |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 10,408,860 | — | |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 6,757,090 | — | |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 4,305,906 | — | |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 607,161 | — | |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 17,001 | — | |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 2,081,772 | — | |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 765,736 | — | deriv |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 603,920 | — | deriv |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 6,245,316 | — | deriv |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 31,226,580 | — | deriv |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 1,201,643 | — | deriv |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 20,244,280 | — | deriv |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 9,763,156 | — | deriv |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 2,309,297 | — | deriv |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 9,274 | — | deriv |
| 31 Oct 2025 | CONVERSION | Navan, Inc. | 41,635 | — | deriv |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 11,433,677 | — | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 12,264 | — | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 17,438,465 | — | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 19,192,015 | — | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 5,000,000 | — | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 2,642,897 | — | deriv |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 1,574,510 | — | deriv |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 2,401,418 | — | deriv |